Breast Nurse Intervention to Improve Adherence to Endocrine Therapy Among Breast Cancer Patients in South Ethiopia

被引:11
|
作者
Getachew, Sefonias [1 ,2 ]
Addissie, Adamu [1 ,2 ]
Seife, Edom [3 ]
Wakuma, Tariku [4 ]
Unverzagt, Susanne [5 ]
Jemal, Ahmedin [6 ]
Taylor, Lesley [7 ]
Wienke, Andreas [2 ]
Kantelhardt, Eva J. [2 ,8 ]
机构
[1] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia
[2] Martin Luther Univ Saale, Inst Med Epidemiol Biometr & Informat, Halle, Germany
[3] Addis Ababa Univ, Tikur Anbessa Hosp, Radiotherapy Ctr, Addis Ababa, Ethiopia
[4] Aira Gen Hosp, Dept Surg, Oromia, Ethiopia
[5] Martin Luther Univ Halle Saale, Ctr Hlth Sci, Inst Gen Practice & Family Med, Halle, Germany
[6] Amer Canc Soc, Atlanta, GA 30329 USA
[7] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[8] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Germany
来源
ONCOLOGIST | 2022年 / 27卷 / 08期
关键词
breast cancer; adherence; tamoxifen; breast nurse; peripheral hospitals; Ethiopia; SUB-SAHARAN AFRICA; ADJUVANT; WOMEN; TAMOXIFEN; CARE; IMPLEMENTATION; SURVIVORS; INCOME;
D O I
10.1093/oncolo/oyac081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Many women in rural Ethiopia do not receive adjuvant therapy following breast cancer surgery despite the majority being diagnosed with estrogen-receptor-positive breast cancer and tamoxifen being available in the country. We aimed to compare a breast nurse intervention to improve adherence to tamoxifen therapy for breast cancer patients. Methods and Materials The 8 hospitals were randomized to intervention and control sites. Between February 2018 and December 2019, patients with breast cancer were recruited after their initial surgery. The primary outcome of the study was adherence to tamoxifen therapy by evaluating 12-month medication-refill data with medication possession ratio (MPR) and using a simplified medication adherence scale (SMAQ) in a subjective assessment. Results A total of 162 patients were recruited (87 intervention and 75 control). Trained nurses delivered education and provided literacy material, gave additional empathetic counselling, phone call reminders, and monitoring of medication refill at the intervention hospitals. Adherence according to MPR at 12 months was high in both the intervention (90%) and control sites (79.3%) (P = .302). The SMAQ revealed that adherence at intervention sites was 70% compared with 44.8% in the control sites (P = .036) at 12 months. Persistence to therapy was found to be 91.2% in the intervention and 77.8% in the control sites during the one-year period (P = .010). Conclusion Breast nurses can improve cost-effective endocrine therapy adherence at peripheral hospitals in low-resource settings. We recommend such task sharing to overcome the shortage of oncologists and distances to central cancer centers. In Ethiopia, most patients are estrogen-receptor-positive and could benefit from an endocrine therapy such as tamoxifen; however, endocrine therapy is under-utilized in the country. This article describes a trained breast nurse intervention that was implemented to improve adherence to tamoxifen therapy.
引用
收藏
页码:E650 / E660
页数:11
相关论文
共 50 条
  • [1] Interventions to improve oral endocrine therapy adherence in breast cancer patients
    Ganna, Sourab
    Rahimi, Sama
    Lu, Anh
    Laborde, Krista
    Trivedi, Meghana
    [J]. JOURNAL OF CANCER SURVIVORSHIP, 2024,
  • [2] DEVELOPMENT OF A BILINGUAL MOBILE APP TO IMPROVE ADHERENCE TO ENDOCRINE HORMONE THERAPY AMONG BREAST CANCER PATIENTS
    Chalela, Patricia
    Munoz, Edgar
    Fernandez, Andrea
    Despres, Cliff
    Inupakutika, Devasena
    Basutkar, Chetan
    Akopian, David
    Ramirez, Amelie
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S629 - S629
  • [3] Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
    Rosso, Roberta
    D'Alonzo, Marta
    Bounous, Valentina Elisabetta
    Actis, Silvia
    Cipullo, Isabella
    Salerno, Elena
    Biglia, Nicoletta
    [J]. CURRENT ONCOLOGY, 2023, 30 (02) : 1461 - 1472
  • [4] Adherence to endocrine therapy for breast cancer
    Chlebowski, Rowan T.
    Geller, Michelle L.
    [J]. ONCOLOGY, 2006, 71 (1-2) : 1 - 9
  • [5] COPING AND ENDOCRINE THERAPY ADHERENCE AMONG WOMEN WITH BREAST CANCER
    Bright, Emma E.
    Stanton, Annette L.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S89 - S89
  • [6] IDENTIFYING ADHERENCE BARRIERS TO ORAL ENDOCRINE THERAPY (OET) AMONG BREAST CANCER PATIENTS
    Paranjpe, R.
    Trivedi, M.
    Abughosh, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [7] Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients
    Arriola, Kimberly R. Jacob
    Mason, Tamara A.
    Bannon, Kari Ann
    Holmes, Carol
    Powell, Cecil Lamonte
    Horne, Kandra
    O'Regan, Ruth
    [J]. PATIENT EDUCATION AND COUNSELING, 2014, 95 (01) : 98 - 103
  • [8] Endocrine Therapy for Breast Cancer Patients in South Africa
    Bazargani, Yaser T.
    de Boer, Anthonius
    Leufkens, Hubertus G. M.
    Mantel-Teeuwisse, Aukje K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 70 - 71
  • [9] BARRIERS TO AND FACILITATORS OF ENDOCRINE THERAPY ADHERENCE AMONG WOMEN WITH BREAST CANCER
    Bright, Emma E.
    Stanton, Annette L.
    Petrie, Keith J.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S290 - S290
  • [10] Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
    Ekim Ekinci
    Salima Nathoo
    Thushara Korattyil
    Aisha Vadhariya
    Hanna A. Zaghloul
    Polly A. Niravath
    Susan M. Abughosh
    Meghana V. Trivedi
    [J]. Journal of Cancer Survivorship, 2018, 12 : 348 - 356